tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market

Fate Therapeutics (FATE) Technical Analysis

Compare
1,169 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Fate Therapeutics’s (FATE) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Fate Therapeutics is a Sell.
Fate Therapeutics’s (FATE) 20-Day exponential moving average is 0.97, while Fate Therapeutics’s (FATE) share price is $0.85, making it a Sell.
Fate Therapeutics’s (FATE) 50-Day exponential moving average is 1.21, while Fate Therapeutics’s (FATE) share price is $0.85, making it a Sell.

Fate Therapeutics (FATE) Pivot Points

Mar 29, 2025, 06:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.79
0.81
0.85
0.87
0.90
0.92
0.95
Fibonacci
0.81
0.83
0.85
0.87
0.89
0.90
0.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Fate Therapeutics (FATE) Moving Averages

Mar 29, 2025, 06:45 AM
Period
Simple
Exponential
MA5
0.88Sell
0.88Sell
MA10
0.91Sell
0.90Sell
MA20
0.94Sell
0.97Sell
MA50
1.17Sell
1.21Sell
MA100
1.65Sell
1.67Sell
MA200
2.65Sell
2.57Sell
Fate Therapeutics’s (FATE) 10-Day exponential moving average is 0.90, while Fate Therapeutics’s (FATE) share price is $0.85, making it a Sell.
Fate Therapeutics’s (FATE) 100-Day exponential moving average is 1.67, while Fate Therapeutics’s (FATE) share price is $0.85, making it a Sell.
Fate Therapeutics’s (FATE) stock price is $0.85 and Fate Therapeutics’s (FATE) 50-day simple moving average is 1.17, creating a Sell signal.
Fate Therapeutics’s (FATE) stock price is $0.85 and Fate Therapeutics’s (FATE) 100-day simple moving average is 1.65, creating a Sell signal.
Fate Therapeutics’s (FATE) stock price is $0.85 and Fate Therapeutics’s (FATE) 200-day simple moving average is 2.65, creating a Sell signal.

Fate Therapeutics (FATE) Technical Indicators

Mar 29, 2025, 06:45 AM
Name
Value
Implied Action
RSI (14)
36.99
Neutral
STOCH (9,6)
15.33
Buy
STOCHRSI (14)
11.93
Buy
MACD (12,26)
-0.10
Sell
ADX (14)
19.90
Buy
Williams %R
-91.37
Buy
CCI (14)
-157.24
Buy
ATR (14)
0.09
-
Ultimate Oscillator
44.96
Neutral
ROC
-8.60
Sell
Fate Therapeutics’s (FATE) Relative Strength Index (RSI) is 36.99, creating a Neutral signal.
Fate Therapeutics’s (FATE) Trend Strength Indicator (ADX) is 19.90, creating a Buy signal.
Fate Therapeutics’s (FATE) Commodity Channel Index (CCI) is -157.24, creating a Buy signal.
Fate Therapeutics’s (FATE) Price Rate of Change (ROC) is -8.60, creating a Sell signal.

FAQ

Is FATE a Buy, Hold, or Sell?
Based on FATE’s technical indicators, FATE is a Sell.
    What is FATE’s RSI (14)?
    FATE’s RSI (14) is 36.99, which suggests FATE is a Neutral.
      What is FATE’s MACD?
      FATE’s MACD is -0.10, which suggests FATE is a Sell.
        What is FATE’s 5-day moving average?
        FATE’s 5-day moving average is 0.88, which suggests FATE is a Sell.
          What is FATE’s 20-day moving average?
          FATE 20-day moving average is 0.94, which suggests FATE is a Sell.
            What is FATE’s 50-day moving average?
            FATE’s 50-day moving average is 1.17, which suggests FATE is a Sell.
              What is FATE’s 200-day moving average?
              FATE’s 200-day moving average is 2.65, which suggests FATE is a Sell.
                What is FATE’s Williams % R (14)?
                FATE’s Williams % R (14) is -91.37, which suggests FATE is a Buy.
                  What is FATE’s CCI (14)?
                  FATE’s CCI (14) is -157.24, which suggests FATE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis